QuinXell Technologies Pte Ltd was founded in 2011 as a member of Quintech Life Sciences (www.quintechlifesciences.com). QuinXell’s core expertise lies in the emerging field of Regenerative Medicine, through her innovative cell culture technologies.
The TisXell Regeneration System has its origins as a joint collaboration between the National University of Singapore (NUS) and the Singapore Polytechnic (SP). The introduction of TisXell is the outcome of intensive research and engineering, illustrated by published articles in international journals.
TisXell’s patented biaxial revolution, with its uniquely designed spherical culture chamber, accelerates homogeneous cell development to viable 3D tissue constructs. Growth uniformity is maintained on the surface and within the core, attributing to structural integrity of tissues and organs upon implant. The Nautilis aptly represents this consistent cell expansion, with its self-similar and self-congruent spiral, the Spira mirabilis (miraculous spiral).
Since its inception and launch, TisXell has rapidly gained acceptance as the gold standard in tissue culture.